Recent advances in recombinant adeno-associated virus vector production

Kidney International

Volumn 61, Issue SUPPL. 1, 2002, Pages

  Clark, K Reed ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

AAV; rAAV production; Stable cell lines

Indexed keywords

ADENOVIRUS VECTOR;

CELL LINE; CONFERENCE PAPER; DNA TRANSFECTION; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSFER; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

EID: 0036175095     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.0610s1009.x     Document Type: Conference Paper

References (41)

1. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
2. Adeno-associated virus general transduction vectors: Analysis of proviral structures
3. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
4. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products
5. The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production
6. Role for highly regulated rep gene expression in adeno-associated virus vector production
7. Novel tools for production and purification of recombinant adeno-associated virus vectors
8. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
9. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
10. A helper virus-free packaging system for recombinant adeno-associated virus vectors
11. Adeno-associated virus vectors can be efficiently produced without helper virus
12. Factors influencing recombinant adeno-associated virus production
13. Control of adeno-associated virus type 2 cap gene expression: Relative influence of helper virus, terminal repeats, and Rep proteins
14. Subcellular compartmentalization of adeno-associated virus type 2 assembly
15. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6
16. Cell lines for the production of recombinant adeno-associated virus
17. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonatad cellulose column chromatography
18. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
19. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors
20. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus
21. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap
22. Replication and packaging of HIV envelope genes in a novel adeno-associated virus vector system
23. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
24. Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase
25. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome
26. Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6
27. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap
28. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV
29. High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors
30. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H
31. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors
32. Selective rep-cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines
33. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome
34. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
35. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
36. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus
37. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors
38. Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results
39. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction
40. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination
41. Identification and elimination of replication-competent adeno-associated virus (AAV) that arise by nonhomologous recombination during AAV vector production